1.08
price up icon0.00%   0.00
after-market After Hours: 1.12 0.04 +3.70%
loading
Atai Life Sciences N V stock is traded at $1.08, with a volume of 533.52K. It is up +0.00% in the last 24 hours and down -6.90% over the past month. ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.
See More
Previous Close:
$1.08
Open:
$1.1
24h Volume:
533.52K
Relative Volume:
0.88
Market Cap:
$180.38M
Revenue:
$314.00K
Net Income/Loss:
$-40.23M
P/E Ratio:
-1.1739
EPS:
-0.92
Net Cash Flow:
$-84.71M
1W Performance:
-5.26%
1M Performance:
-6.90%
6M Performance:
-47.32%
1Y Performance:
-18.18%
1-Day Range:
Value
$1.05
$1.12
1-Week Range:
Value
$1.04
$1.1757
52-Week Range:
Value
$1.025
$2.85

Atai Life Sciences N V Stock (ATAI) Company Profile

Name
Name
Atai Life Sciences N V
Name
Phone
(617)-699-5876
Name
Address
WALLSTRASSE 16, BERLIN
Name
Employee
83
Name
Twitter
Name
Next Earnings Date
2024-12-05
Name
Latest SEC Filings
Name
ATAI's Discussions on Twitter

Atai Life Sciences N V Stock (ATAI) Upgrades & Downgrades

Date Action Analyst Rating Change
Nov-01-22 Initiated Loop Capital Buy
Nov-30-21 Initiated Maxim Group Buy
Nov-11-21 Initiated ROTH Capital Buy
Oct-18-21 Initiated H.C. Wainwright Buy
Sep-01-21 Initiated Jefferies Buy
Jul-13-21 Initiated Berenberg Buy
Jul-13-21 Initiated Canaccord Genuity Buy
Jul-13-21 Initiated Cantor Fitzgerald Buy
Jul-13-21 Initiated Citigroup Buy
Jul-13-21 Initiated Cowen Outperform
Jul-13-21 Initiated Credit Suisse Outperform
Jul-13-21 Initiated RBC Capital Mkts Sector Perform
Jul-08-21 Initiated Aegis Capital Buy
View All

Atai Life Sciences N V Stock (ATAI) Latest News

pulisher
Oct 15, 2024

Are ATAI Life Sciences N.V.’shares a good deal? - US Post News

Oct 15, 2024
pulisher
Oct 15, 2024

Insider Sale Alert: ATAI Life Sciences N.V. [ATAI] – Is it Time to sell? - Knox Daily

Oct 15, 2024
pulisher
Oct 15, 2024

atai Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit - StockTitan

Oct 15, 2024
pulisher
Oct 11, 2024

Selling Buzz: ATAI Life Sciences N.V. [ATAI] 10% Owner ATAI Life Sciences N.V. sells 2,660,000 shares of the company - Knox Daily

Oct 11, 2024
pulisher
Oct 11, 2024

ATAI Life Sciences N.V. (ATAI)’s results reveal risk - US Post News

Oct 11, 2024
pulisher
Oct 07, 2024

Maxim Group gives a Buy recommendation for ATAI Life Sciences N.V. (ATAI) - Knox Daily

Oct 07, 2024
pulisher
Oct 05, 2024

ATAI Life Sciences completes acquisition of IntelGenx Corp. - Investing.com India

Oct 05, 2024
pulisher
Oct 04, 2024

ATAI Life Sciences completes acquisition of IntelGenx Corp. By Investing.com - Investing.com South Africa

Oct 04, 2024
pulisher
Oct 03, 2024

10% Owner ATAI Life Sciences N.V. sale 2,660,000 shares of ATAI Life Sciences N.V. [ATAI] - Knox Daily

Oct 03, 2024
pulisher
Oct 03, 2024

ATAI Life Sciences N.V. (ATAI) stock analysis: A comprehensive overview - US Post News

Oct 03, 2024
pulisher
Oct 01, 2024

Trading Day Review: ATAI Life Sciences N.V. (ATAI) Loses Momentum, Closing at 1.16 - The Dwinnex

Oct 01, 2024
pulisher
Sep 30, 2024

A History of Outperforming Analyst Forecasts and Beating the Odds: ATAI Life Sciences N.V. (ATAI) - SETE News

Sep 30, 2024
pulisher
Sep 30, 2024

Maxim Group Upgrades ATAI Life Sciences N.V. (ATAI) to a Buy from a Hold - Knox Daily

Sep 30, 2024
pulisher
Sep 28, 2024

Life Sciences N.V. Atai Sells 2,660,000 Shares of COMPASS Pathways plc (NASDAQ:CMPS) Stock - MarketBeat

Sep 28, 2024
pulisher
Sep 27, 2024

Atai Life Sciences executives sell shares valued at $16 million - Investing.com India

Sep 27, 2024
pulisher
Sep 26, 2024

Deeper Dive: Understanding ATAI Life Sciences N.V. (ATAI) Through its Various Ratios - The Dwinnex

Sep 26, 2024
pulisher
Sep 26, 2024

ATAI Life Sciences N.V. (ATAI) deserves closer scrutiny - US Post News

Sep 26, 2024
pulisher
Sep 26, 2024

ATAI Life Sciences N.V. [ATAI] Shares Fall Approximately -7.81% Over the Year - Knox Daily

Sep 26, 2024
pulisher
Sep 23, 2024

TWKS SPECIAL ALERT: Thoughtworks Shareholders Seeking More Than $4.40 Per Share Contact Julie & Holleman Regarding Sale to Apax - PR Newswire

Sep 23, 2024
pulisher
Sep 23, 2024

Actinium Pharmaceuticals, Inc. (NYSE:ATNM) Given Average Rating of “Moderate Buy” by Brokerages - Defense World

Sep 23, 2024
pulisher
Sep 20, 2024

T2 Biosystems Achieves Successful Defense of Patent for - GlobeNewswire

Sep 20, 2024
pulisher
Sep 20, 2024

Actinium Pharmaceuticals Announces Publication of Results from the Phase 3 SIERRA Trial of Iomab-B in the Journal of Clinical Oncology - StockTitan

Sep 20, 2024
pulisher
Sep 20, 2024

Magic mushroom market set to go gangbusters, Irish researcher says - Mugglehead

Sep 20, 2024
pulisher
Sep 19, 2024

ATAT’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle

Sep 19, 2024
pulisher
Sep 19, 2024

Applied Therapeutics: AdCom Decision Takes Govorestat Approval A Step Closer (NASDAQ:APLT) - Seeking Alpha

Sep 19, 2024
pulisher
Sep 18, 2024

Athira shifts focus to ALS drug after Alzheimer’s flop - The Pharma Letter

Sep 18, 2024
pulisher
Sep 18, 2024

Australian Clinical Labs Shareholder Stake Shifts - TipRanks

Sep 18, 2024
pulisher
Sep 17, 2024

(ATAT) Trading Advice - Stock Traders Daily

Sep 17, 2024
pulisher
Sep 17, 2024

T2 Biosystems director sells shares worth $133 - Investing.com India

Sep 17, 2024
pulisher
Sep 17, 2024

Atour Lifestyle Holdings Ltd ADR (ATAT) is looking forward to a strong quarter - SETE News

Sep 17, 2024
pulisher
Sep 17, 2024

Atour Lifestyle Holdings Limited (NASDAQ:ATAT) Short Interest Down 8.3% in August - MarketBeat

Sep 17, 2024
pulisher
Sep 17, 2024

Alzheimer’s drug developer Actinogen rattles the tin - The Australian Financial Review

Sep 17, 2024
pulisher
Sep 17, 2024

Substantial Stake Acquired in Australian Clinical Labs - TipRanks

Sep 17, 2024
pulisher
Sep 16, 2024

Cat defies the odds to survive after being born with two faces - MSN

Sep 16, 2024
pulisher
Sep 16, 2024

ATAI Life Sciences N.V. [ATAI] See Remarks makes an insider sale of 151,303 shares worth $0.29 million. - Knox Daily

Sep 16, 2024
pulisher
Sep 16, 2024

T2 Biosystems Receives FDA Clearance to Market the T2Candida Panel for Pediatric Patients - GlobeNewswire

Sep 16, 2024
pulisher
Sep 13, 2024

Two-faced kitten in Phetchabun leaves locals feline lottery curious - Thaiger

Sep 13, 2024
pulisher
Sep 10, 2024

Monitoring ATAI Life Sciences N.V. (ATAI) after recent insider movements - Knox Daily

Sep 10, 2024
pulisher
Sep 10, 2024

Market Watch Highlights: ATAI Life Sciences N.V. (ATAI) Ends on an Upturn Note at 1.24 - The Dwinnex

Sep 10, 2024
pulisher
Sep 04, 2024

ATAI Life Sciences N.V. [ATAI] Insider Activity: An Update for Investors - Knox Daily

Sep 04, 2024
pulisher
Sep 04, 2024

ATAI Life Sciences N.V. (ATAI)’s stock chart: A technical perspective - US Post News

Sep 04, 2024
pulisher
Sep 04, 2024

atai Life Sciences to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - StockTitan

Sep 04, 2024
pulisher
Sep 03, 2024

Psychedelic Drugs Market to Grow by USD 1.37 Billion from 2024-2028, Driven by Increasing Mental Health Disorders, Report Highlights AI's Impact on the Market LandscapeTechnavio - The Malaysian Reserve

Sep 03, 2024
pulisher
Sep 03, 2024

Psychedelic Stock Deep Dive: Atai Life Sciences (ATAI) (NASDAQ:ATAI) - Seeking Alpha

Sep 03, 2024
pulisher
Sep 03, 2024

H.C. Wainwright raises outlook on atai Life Sciences stock as pipeline progresses - Investing.com

Sep 03, 2024
pulisher
Aug 29, 2024

Market Momentum: ATAI Life Sciences N.V. (ATAI) Registers a -1.56 Decrease, Closing at 1.26 - The Dwinnex

Aug 29, 2024
pulisher
Aug 29, 2024

ATAI Life Sciences N.V. (ATAI) presents a great opportunity, but the stock is slightly undervalued - US Post News

Aug 29, 2024
pulisher
Aug 28, 2024

ATAI Life Sciences N.V. (ATAI) may enjoy gains as insiders got busy in the recent days - Knox Daily

Aug 28, 2024
pulisher
Aug 23, 2024

ATAI Life Sciences N.V. [NASDAQ: ATAI] Sees Decrease in Stock Value - Knox Daily

Aug 23, 2024
pulisher
Aug 21, 2024

Can you still get a good price for ATAI Life Sciences N.V. (ATAI) Shares at this point? - US Post News

Aug 21, 2024
pulisher
Aug 19, 2024

Analyzing ATAI Life Sciences N.V. (ATAI) After Recent Trading Activity - Knox Daily

Aug 19, 2024

Atai Life Sciences N V Stock (ATAI) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Cap:     |  Volume (24h):